French Medico-Administrative Data to Identify the Care Pathways of Women With Breast Cancer

    loading  Checking for direct PDF access through Ovid

Abstract

Background

Study of the care pathways is an important topic for care planning, as well as to observe guidelines application. This study aimed to describe care pathways and the period of time between treatments of women with breast cancer (BC), at a population level.

Materials and Methods

Women with in situ, local and regional BC who were hospitalized and newly treated in 2012 were included and followed for 1 year. Care pathways were described, focusing on surgery (partial mastectomy [PM], total mastectomy [TM]), chemotherapy, and radiotherapy. The periods of time between treatments were measured and compared with the guidelines.

Results

The study involved 52,128 women. The most common care pathways among the 2845 women with in situ BC were PM-radiotherapy (46.7%) and TM (28.5%). Among the 41,470 women with local BC, they were: PM-radiotherapy (44.8%) or PM-chemotherapy-radiotherapy (16.0%). The 7813 women with regional BC had similar care pathways, although chemotherapy was given more frequently (73%). The periods of time between surgery and chemotherapy were in accordance with the guidelines for 98% of the women; those between surgery and radiotherapy were affected by adjuvant chemotherapy. Finally, the time between chemotherapy and radiotherapy was longer than recommended for 40% of the women.

Conclusion

The French medicoadministrative databases allow the study, at a national population level, of the care pathways and periods of time between treatments of women with BC according to the stage of the disease. They were close to the guidelines, although an improvement is highly necessary.

Micro-Abstract

Having a better understating of care pathways is of importance for authorities and clinician. This study, based on national medico-administrative database, describes the care pathways and time between treatments of 52,128 women presenting newly-diagnosed breast cancer in 2012 in France, according to the stage of the disease. Although the majority of women were treated according to the guidelines, an improvement is necessary.

Related Topics

    loading  Loading Related Articles